Tag: covid-19 vaccine

AstraZeneca halts COVID-19 vaccine trial for safety review

A major vaccine trial by British-Swedish drugmaker AstraZeneca was halted due to a serious adverse reaction by a participant in the trials. The company plans to have a safety review and minimise the impact on the trial timeline. Meanwhile, the World Health Organisation has started a review of the international health response strategy to the COVID-19 pandemic on Tuesday. Dr Francis Ohanyido, President of the West Africa Academy of Public Health joins CNBC Africa for more.

WHO aiming for 20% of Africa to get initial COVID jabs from access plan

Only two of the potential COVID-19 vaccines are being tested in Africa, said Richard Hatchett, chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI), which co-leads the COVAX project with the WHO and the Gavi vaccines alliance

Moderna COVID-19 vaccine appears to work as well in older adults in early study

The analysis looked at subjects given the 100-microgram dose being tested in the much larger Phase III trial. Moderna said the immune responses in those aged between ages 56 and 70, above age 70 and those 18 to 55-years-old were similar.

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.

Nigeria’s agriculture sector sees positive growth in Q2 despite COVID-19 headwinds

Nigeria’s agriculture sector grew by 1.58 per cent in the second quarter of the year despite the economic headwinds that led to a 6.05 per cent decline of the non-oil sector economy. Nigeria is targeting smallholder farmers to drive the first phase of the Nigeria Economic Sustainability Plan. Chike Nwagwu, CEO of Novus Agro joins CNBC Africa for more.

Assessing Africa’s hunt for the COVID-19 vaccine

The global tally for confirmed COVID-19 cases has surpassed 21 million. The search for a vaccine has seen different countries attempt to put their best foot forward. Nigeria is looking to resume international flight next week Saturday. Niniola Williams, Managing Director of DRASA Health Trust joins CNBC Africa to assess Africa's COVID-19 vaccine hunt.

Novavax begins phase two COVID-19 vaccine trail in SA

The global race for a COVID-19 vaccine has been won by Russia who announced that it has produced the first batch of its vaccine this week. However in South Africa, the motto of slow and steady wins the race is in full effect as American vaccine group Novavax will begin a phase two clinical trial in the country this week. Joining CNBC Africa to unpack more on the progress of South Africa’s COVID-19 vaccine trial is Dr Clare Cutland, Scientific Coordinator for the African Leadership in Vaccinology Expertise Consortium.

Novavax begins mid-stage study of COVID-19 vaccine in South Africa

Novavax said it intends to initiate the Phase 2 portion of this trial in the United States and Australia in the near future and that it would include about 1,500 candidates.

How close is SA to a COVID-19 vaccine?

This week the Unites Stated and the UK have had encouraging updates of their respective Covid-19 vaccine trials, showing promising results which could see a vaccine available as early next year. Back home in South Africa, we are about a month into our vaccine trial and the country is experiencing volatile surges in case numbers, will this be a threat to the progress of the vaccine trial? Joining CNBC Africa for more is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.